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Sequence Space Localization in the Immune System Response to Vaccination and
Disease
Michael W. Deem and Ha Youn Lee
Department of Bioengineering and Department of Physics & Astronomy, Rice University, Houston, TX 77005-1892
We introduce a model of protein evolution to explain limitations in the immune system response
to vaccination and disease. The phenomenon of original antigenic sin, wherein vaccination creates
memory sequences that can increase susceptibility to future exposures to the same disease, is ex-
plained as stemming from localization of the immune system response in antibody sequence space.
This localization is a result of the roughness in sequence space of the evolved antibody affinity
constant for antigen and is observed for diseases with high year-to-year mutation rates, such as
influenza.
PACS numbers: 87.10.+e, 87.15.Aa, 87.17.-d, 87.23.Kg
INTRODUCTION
Our immune system protects us against death by in-
fection [1]. A major component of the immune system
is generation of antibodies, protein molecules that bind
specific antigens. To recognize invading pathogens, the
immune system performs a search of the amino acid se-
quence space of possible antibodies. To find useful anti-
bodies in the effectively infinite protein sequence space,
the immune system has evolved a hierarchical strategy.
The first step involves creating the DNA sequences for
B cells that code for moderately effective antibodies
through rearrangement of immune-system-specific gene
fragments from the genome [2]. This process is called
VDJ recombination. This combinatorial process can pro-
duce on the order of 1014 different antibodies through
recombination of pieces of antibodies. The second step,
which occurs when a specific antigen invades our body,
is somatic hypermutation. Somatic hypermutation is the
process of mutation that occurs when the B cells that pro-
duce the antibodies divide and multiply. Only those B
cells that produce antibodies that bind the antigen with
higher affinity are propagated by this mutation and selec-
tion process, and another name for this process is affin-
ity maturation. Somatic hypermutation is essentially a
search of the amino acid sequence space at the level of
individual point mutations [3].
The consequence of an immune system response to
antigen is the establishment of a state of memory [4].
Immunological memory is the ability of the immune sys-
tem to respond more rapidly and effectively to antigens
that have been encountered previously. Specific memory
is maintained in the DNA of long-lived memory B cells
that can persist without residual antigen.
Although our immune system is highly effective, some
limitations have been reported. The phenomenon known
as “original antigenic sin” is the tendency for antibodies
produced in response to exposure to influenza virus anti-
gens to suppress the creation of new, different antibodies
in response to exposure to different versions of the flu [5].
Roughly speaking, the immune system responds only to
the antigen fragments, or epitopes, that are in common
with the original flu virus. As a result, individuals vac-
cinated against the flu may become more susceptible to
infection by mutated strains of the flu than would in-
dividuals receiving no vaccination. The details of how
original antigenic sin works, even at a qualitative level,
are unknown.
In this Letter, we offer an explanation for the reported
limitations in the immune system response using a model
of protein evolution. We describe the dynamics of affin-
ity maturation by a search for increased binding con-
stants between antibody and antigen in antibody se-
quence space. It is shown that an immune system re-
sponse to an antigen generates localized memory B cell
sequences. This set of localized sequences reduces the
ability of the immune system to respond to subsequent
exposures to different but related antigens. It is this com-
petitive process between memory sequences and the VDJ
recombinations of secondary exposure that is responsible
for the reported limitations in the immune system.
We use a random energy model to represent the inter-
action between the antibodies and the influenza proteins.
This model captures the essence of the correlated rugged-
ness of the interaction energy in the variable space, the
variables being the antibody amino acid sequences and
the identity of the disease proteins, and the correlations
being mainly due to the physical structure of the anti-
bodies. The random energy model allows study of the
sequence-level dynamics of the immune/antigen system,
which would otherwise be an intractable problem at the
atomic scale, with 104 atoms per antibody, 108 antibod-
ies per individual, 6 × 109 individuals, and many possi-
ble influenza strains. Use of random energy theory to
treat correlations in otherwise intractable physical sys-
tems goes back at least to Bohr’s random matrix theory
for nuclear cross sections [6] and has been used for quan-
tum chaos, disordered mesoscopic systems, QCD, and
quantum gravity [7]. Close to the present application is
the study of spin glasses by random energy models [8, 9],
protein folding by coarse-grained models [10, 11], and
2evolutionary systems by NK-type models [12, 13, 14, 15].
In detail, the generalized NK model we use considers
three different kinds of interactions within an antibody:
interaction within a subdomain (U sd), interactions be-
tween subdomains (U sd−sd), and direct binding interac-
tion between antibody and antigen (U c). In the context
of protein evolution, parameters of the model have been
calibrated [12, 16, 17]. The energy function of a protein
is given by
U =
M∑
i=1
U sdαi +
M∑
i>j=1
U sd−sdij +
P∑
i=1
U ci , (1)
whereM is the number of antibody secondary structural
subdomains, and P is the number of antibody amino
acids contributing directly to the binding. The subdo-
main energy U sd is
U sdαi =
1√
M(N −K + 1)
N−K+1∑
j=1
σαi(aj , aj+1, ···, aj+K−1),
(2)
where N is the number of amino acids in a subdomain,
and K is the range of local interaction within a subdo-
main. All subdomains belong to one of L = 5 different
types (e.g., helices, strands, loops, turns, and others).
The quenched Gaussian random number σαi is different
for each value of its argument for a given subdomain
type, αi. All of the Gaussian σ values have zero mean
and unit variance. The energy of interaction between
secondary structures is
U sd−sdij =
√
2
DM(M − 1)
D∑
k=1
σkij(a
i
j1
, · · ·, aijK/2 ;
ajjK/2+1 , · · ·, a
j
jK
) .
(3)
We set the number of interactions between secondary
structures at D = 6. Here σkij and the interacting
amino acids, j1, · · ·, jK , are selected at random for each
interaction (k, i, j). The chemical binding energy of
each antibody amino acid to the antigen is given by
U ci = σi(ai)/
√
P . The contributing amino acid, i, and
the unit-normal weight of the binding, σi, are chosen
at random. Using experimental results, we take P = 5
amino acids to contribute directly to the binding event.
Here we consider only five chemically distinct amino acid
classes (e.g., negative, positive, polar, hydrophobic, and
other) since each different type of amino acid behaves as
a completely different chemical entity within the random
energy model.
The generalized NK model, while a simplified descrip-
tion of real proteins, captures much of the thermodynam-
ics of protein folding and ligand binding. In the model,
a specific B cell repertoire is represented by a specific set
of amino acid sequences. Moreover, a specific instance
of the random parameters within the model represents a
specific antigen. An immune response that finds a B cell
that produces an antibody with high affinity constant to
a specific antigen corresponds in the model to finding a
sequence having a low energy for a specific parameter set.
The random character of the generalized NK model
makes the energy rugged in antibody sequence space.
The energy is, moreover, correlated by the local anti-
body structure (K = 4), the secondary antibody struc-
ture (U sd−sd), and the interaction with the influenza pro-
teins (U c). As the immune system explores the space of
possible antibodies, localization is possible if the corre-
lated ruggedness of the interaction energy is sufficiently
great.
Since the variable region in each light and heavy chain
of an antibody is about 100 amino acids long, and most
of the binding occurs in the heavy chain, we choose a
sequence length of 100. We choose M = 10 since there
are roughly 10 secondary structures in a typical antibody
and thus choose N = 10. The immune system contains of
the order of 108 B cells divided into different specificities,
and the frequency of a specific B cell participating in the
initial immune response is roughly 1 in 105 [18]. Hence,
we use 103 sequences during an immune response.
The hierarchical strategy of the immune system is used
to search the antibody sequence space for high affinity an-
tibodies. Initial combination of optimized subdomains is
followed by a point mutation and selection procedure [12].
To mimic combinatorial joining of gene segments during
B cell development, we produce a naive B cell repertoire
by choosing each subdomain sequence from pools that
have Npool amino acid segments obtained by minimizing
the appropriate U sd. To fit the theoretical heavy-chain
diversity of 3× 1011 [18], we choose Npool = 3 sequences
among the top 300 sequences for each subdomain type.
Somatic hypermutation occurs at the rate of roughly
one mutation per variable regions of light and heavy
chains per cell division, which occurs every 6 to 8 hours
during intense cell proliferation [19]. Hence, in our sim-
ulation, we do 0.5 point mutations per sequence, keep
the best (highest affinity) x = 20% sequences, and then
amplify these back up to a total of 103 copies in one
round, which corresponds to 1/3 day. That is, the prob-
ability of picking one of the, possibly mutated, sequences
for the next round is pselect = 1/200 for U ≤ U200 and
pselect = 0 for U > U200, where U200 is the 200th best en-
ergy of the 103 sequences after the mutation events, and
this equation is employed 103 times to select randomly
the 103 sequences for the next round. Given a specific
antigen, i.e. a specific set of interaction parameters, we
do 30 rounds (10 days) of point mutation and selection
in one immune response. In this way, memory B cells for
the antigen are generated.
The affinity constant is given as a function of energy,
Keq = exp(a− bU) , (4)
3where a and b are determined by the dynamics of the
mutation and selection process. Affinity constants re-
sulting from VDJ recombination are roughly 104, affinity
constants after the first response of affinity maturation
are roughly 106, and affinity constants after a second re-
sponse of affinity maturation are roughly 107 [18] (values
that fix the selection strength, x). By comparison to the
dynamics of the model, we obtain a = −18.56, b = 1.67.
The memory B cells, key to immunological memory,
give rapid and effective response to the same antigen
due to their increased affinity for previously-encountered
antigens. We focus on the role of the memory cells in
the immune response to different antigens. The distance
between a first antigen and the second antigen is given
by the probability, p, of changing parameters of inter-
action within subdomain (U sd), subdomain-subdomain
(U sd−sd), and chemical binding (U c) terms. Within U sd,
we change only the subdomain type, αi, not the param-
eters σα, which are probably fixed by structural biology
and should be independent of the antigen.
We estimate the number of memory and naive B cells
that participate in the immune response to the second
antigen by the ratio of the respective affinity constants.
From the definition of the affinity constant, Keq =
[Antigen : Antibody] / {[Antigen] [Antibody]}, the bind-
ing probability is proportional to the affinity constant
and to the concentration of antigen-specific antibody,
which is 102 times greater for the memory sequences [18].
We measure the average affinity for the second antigen
of the 103 memory cells, Keqm , and that of the 10
3 B
cells from the naive repertoire of optimized subdomain
sequences, Keqn . The ratio 10
2Keqm /K
eq
n gives the ratio of
memory cells to naive cells. For exposure to the second
antigen, we perform 30 rounds (10 days) of point muta-
tion and selection, starting with 105Keqm /(10
2Keqm +K
eq
n )
memory cells and 103Keqn /(10
2Keqm + K
eq
n ) naive cells,
since both memory and naive sequences participate in
the secondary response [20].
Figure 1 shows the evolved affinity constant to a sec-
ond antigen if the exposure to a first antigen exists (solid
line) or not (dashed line) as a function of the difference
between the first and second antigen, p, or “antigenic dis-
tance” [21]. When the difference is small, the exposure
to a first antigen leads to higher affinity constant than
without exposure, which is why immune system mem-
ory and vaccination is effective. For a large difference,
the antigen encountered in the first exposure is uncorre-
lated with that in the second exposure, and so immune
system memory does not play a role. Interestingly, the
immunological memory from the first exposure actually
gives worse protection, i.e. a lower affinity constant, for
intermediate differences—which is original antigenic sin.
The dynamics of the immune response (Fig. 1) depend
upon the constants of Nature, i.e. the parameters of the
model. For example, in an organism with a smaller im-
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FIG. 1: The evolved affinity constant to a second antigen
after exposure to an original antigen that differs by proba-
bility p (solid line). The dotted line represents the affinity
constant without previous exposure. The affinity constant is
generated by exponentiating, as in Eq. (4), the average of the
best binding energy, using 5000 instances of the model. In
inset is shown the affinity of the memory sequences for the
mutated antigen.
mune system, such as the mouse, there are fewer start-
ing sequences and less favorable binding constants are
measured in the same number of rounds: a factor of 0.5
reduction in the number of starting sequences leads to a
0.64 reduction in the evolved binding constant, but a sim-
ilar degree of original antigenic sin as in Fig. 1. On the
other hand, if more rounds are performed, better bind-
ing constants are found in the primary and secondary
responses, but the secondary response is not as improved
over the primary response as when using 30 rounds, be-
cause the evolved sequences are becoming more localized
in ever deeper wells. The degree of original antigenic sin
is, however, similar in the range of 30 to 60 rounds per
response. Similarly, if the roughness of the energy upon
disease mutation is increased, for example by assuming
that mutation of the influenza actually changes the σα,
the degree of original antigenic sin increases substantially,
by a factor of 2, because the barriers between the regions
of localization in sequence space are increased. On the
other hand, if the concentration of the memory cells is
decreased, the contribution of the memory cells to the
dynamics is reduced, and the original antigenic sin phe-
nomenon decreases, almost disappearing when the mem-
ory and naive antibody concentrations are equal. The
average number of mutations leading to the best anti-
body, a measure of the localization length when origi-
nal antigenic sin occurs, is 15 for the first response and
rises from 5 to 15 for the second response in the range
0 ≤ p < 0.30. Interestingly, the average number of muta-
tions rises slightly above 15 in the range 0.30 ≤ p < 0.70,
indicating that in the original antigenic sin region more
4mutations are necessary for the compressed ensemble of
memory sequences from the primary response to evolve to
a suitable new state in the secondary response. Larger
selection strengths (x < 20%) cause more localization
and original antigenic sin, in shallower wells for small x,
and smaller strengths (x > 20%) lead to less evolution.
For small values of p, p < 0.19, the memory B cells
produce antibodies with higher affinities, Keqm > 10
4,
for the new antigen than do naive B cells. The bind-
ing constant of the memory antibodies steadily decreases
with p, reaching the non-specific value of Keqm = 10
2 at
p = 0.36 (see inset in Fig. 1), which, interestingly, is less
than the range to which original antigenic sin extends,
0.23 < p < 0.60. These model predictions are in good
agreement with experimental data on cross-reactivity,
which ceases to occur when the amino acid sequences
are more than 33–42% different [22].
The ineffectiveness of immune system memory over a
window of p values can be understood from the local-
ization of memory B cell sequences. Figure 2 displays
distributions of memory and naive affinity constants for
the second antigen. Notice that the memory sequences
are highly homogeneous and lack diversity compared to
the naive sequences. Indeed, original antigenic sin arises
mainly because the memory sequences from the primary
response suppress use of naive sequences in the tail of the
distribution for the secondary response. Although those
naive sequences initially look unpromising, they may ac-
tually evolve to sequences with superior binding con-
stants. The inset to Fig. 2 illustrates this phenomenon.
Interestingly, when half of the distribution is removed,
the reduction in the binding constant is just about that
which occurs in original antigenic sin, Fig. 1.
In summary, the generalized NKmodel is shown to suc-
cessfully model immune system dynamics. A localization
mechanism for the original antigenic sin phenomenon ob-
served in the flu is explained. Localization of antibod-
ies in the amino acid sequence space around memory B
cell sequences is shown to lead to a decreased ability of
the immune system to respond to diseases with year-to-
year mutation rates within a critical window. This local-
ization occurs because of the ruggedness of the evolved
affinity constant in amino acid sequence space. From
the model dynamics, we find that memory sequences can
both outcompete the non-vaccinated immune response
and become trapped in local minima. Memory sequences
with affinity constants initially superior to those from
naive sequences can be selected by the dynamics, and
these memory sequences can lead to poorer evolved affin-
ity constants, to the detriment of the immune system for
intermediate disease mutation rates. These results sug-
gest several implications for vaccination strategy: the dif-
ference between vaccinations administered on a repeated
basis should be as great as practicable, and suppression
of the memory B cell response may be helpful during
vaccination against highly variable antigens.
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FIG. 2: The affinity distribution of antibodies from naive
B cells (hatched) or memory cells (open) for the antigen of
second exposure. In the inset is shown the binding constant
that evolves in the primary response when an initial selection
step retains only the top fraction of the naive cells.
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